Ensign Peak Advisors, Inc Bristol Myers Squibb CO Transaction History
Ensign Peak Advisors, Inc
- $58.8 Billion
- Q3 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 2,393,799 shares of BMY stock, worth $112 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,393,799
Previous 2,214,043
8.12%
Holding current value
$112 Million
Previous $135 Million
20.05%
% of portfolio
0.18%
Previous 0.26%
Shares
23 transactions
Others Institutions Holding BMY
# of Institutions
2,717Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...